phenytoin has been researched along with Idiopathic Parkinson Disease in 11 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Diphenylhydantoin (DPH) diminished the therapeutic effects of levodopa both in patients with parkinsonism and in patients with chronic manganese poisoning, as well as the levodopa-dependent dyskinesia for which the former were selected." | 3.65 | Diphenylhydantoin. Blocking of levodopa effects. ( Cotzias, GC; Mena, I; Mendez, JS; Papavasiliou, PS, 1975) |
| "The phenytoin treatment causes cerebellar defect and anemia." | 2.82 | The interplay of epilepsy with impaired mitophagy and autophagy linked dementia (MAD): A review of therapeutic approaches. ( Agrawal, M; Dhurandhar, Y; Panda, SP, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (63.64) | 18.7374 |
| 1990's | 3 (27.27) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Panda, SP | 1 |
| Dhurandhar, Y | 1 |
| Agrawal, M | 1 |
| Peeters, EA | 1 |
| Bloem, BR | 1 |
| Kuiper, MA | 1 |
| Vermeij, P | 1 |
| de Wolff, FA | 2 |
| Wolters, EC | 1 |
| Roos, RA | 1 |
| Ferrari, MD | 2 |
| Mendez, JS | 1 |
| Cotzias, GC | 1 |
| Mena, I | 1 |
| Papavasiliou, PS | 1 |
| Núñez, JC | 1 |
| Alonso, MD | 1 |
| Santafé, C | 1 |
| Escamilla, B | 1 |
| Clarke, BM | 1 |
| Upton, A | 1 |
| Griffin, H | 1 |
| Hudoba, P | 1 |
| Boomsma, F | 1 |
| Meerwaldt, JD | 1 |
| Man in't Veld, AJ | 1 |
| Hovestadt, A | 1 |
| Schalekamp, MA | 1 |
| Vermey, P | 1 |
| Veenema, H | 1 |
| Buruma, OJ | 1 |
| Christensen, LK | 1 |
| Skovsted, L | 1 |
| Gilland, O | 1 |
| Pakszys, W | 1 |
| Domzal, T | 1 |
2 reviews available for phenytoin and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
The interplay of epilepsy with impaired mitophagy and autophagy linked dementia (MAD): A review of therapeutic approaches.
Topics: Anticonvulsants; Carbamazepine; Dementia; Epilepsy; Felbamate; Gabapentin; Humans; Inflammasomes; La | 2022 |
[Pathomechanism and pharmacological treatment of Parkinson's disease].
Topics: Acetylcholine; Alkaloids; Dihydroxyphenylalanine; Dopamine; Epinephrine; Histocytochemistry; Humans; | 1971 |
9 other studies available for phenytoin and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
Phenytoin parahydroxylation is not impaired in patients with young-onset Parkinson's disease.
Topics: Administration, Oral; Adult; Age Factors; Cytochrome P-450 Enzyme System; Female; Humans; Hydroxylat | 1994 |
Diphenylhydantoin. Blocking of levodopa effects.
Topics: Adult; Aged; Dopamine; Female; Humans; Huntington Disease; Levodopa; Male; Manganese Poisoning; Midd | 1975 |
[Encephalopathy caused by phenytoin].
Topics: Aged; Brain Diseases; Female; Humans; Parkinson Disease; Phenytoin | 1992 |
Balance and cognitive impairment in two epileptic patients before and after vagal nerve stimulation.
Topics: Adult; Carbamazepine; Cognition; Electric Stimulation Therapy; Epilepsy, Temporal Lobe; Humans; Male | 1991 |
Treatment of idiopathic parkinsonism with L-dopa in the absence and presence of decarboxylase inhibitors: effects on plasma levels of L-dopa, dopa decarboxylase, catecholamines and 3-O-methyl-dopa.
Topics: Administration, Oral; Aged; Benserazide; Carboxy-Lyases; Catecholamines; Dopa Decarboxylase; Drug Co | 1989 |
Hepatic cytochrome P450 malfunction and Parkinson's disease.
Topics: Aged; Female; Humans; Liver; Male; NADPH-Ferrihemoprotein Reductase; Oxidoreductases; Parkinson Dise | 1986 |
Inhibition of drug metabolism by chloramphenicol.
Topics: Aged; Biotransformation; Carbon Isotopes; Chloramphenicol; Chromatography, Thin Layer; Dicumarol; Hu | 1969 |
[American neurology for Swedish use].
Topics: Adrenocorticotropic Hormone; Ampicillin; Brain Diseases; Cerebrovascular Disorders; Contrast Media; | 1968 |
[Effect of diphenylhydantoin on the clinical manifestations and excretion of 5-hydroxyindoloacetic acid in Parkinson's disease].
Topics: Adult; Aged; Brain; Humans; Hydroxyindoleacetic Acid; Middle Aged; Muscle Tonus; Parkinson Disease; | 1972 |